Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Of Colorado Hospital, Aurora, Colorado, United States
Contact: Study coordinator (Chelsey Cartwright) · chelsey.cartwright@cuanschutz.edu · 720-848-0741
Contact: Principal Investigator (Breelyn Wilky, MD)

Study leads

Breelyn Wilky, MD
Principal Investigator
University of Colorado, Denver

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

Abroad (travel likely)RecruitingPHASE2

Hanzhong, China

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Metastatic Dedifferentiated Liposarcoma · Metastatic Leiomyosarcoma · Metastatic Myxofibrosarcoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Los Angeles, United States

Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes

Metastatic Ewing Sarcoma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Phoenix, United States

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Soft-tissue Sarcoma · Triple Negative Breast Cancer · Non-small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orange, United States